Peter Horby
#81,112
Most Influential Person Now
British infectious disease epidemiologist
Peter Horby's AcademicInfluence.com Rankings
Peter Horbymedical Degrees
Medical
#960
World Rank
#1237
Historical Rank
Epidemiology
#254
World Rank
#271
Historical Rank
Peter Horbybiology Degrees
Biology
#6765
World Rank
#9554
Historical Rank
Virology
#143
World Rank
#148
Historical Rank
Download Badge
Medical Biology
Peter Horby's Degrees
- PhD Virology University of Oxford
Why Is Peter Horby Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sir Peter William Horby is a British physician, epidemiologist, Moh Family Foundation Professor of Emerging Infections and Global Health, and Director of the Pandemic Sciences Institute at the University of Oxford. He is the founder, and former director of the Oxford University Clinical Research Unit in Hanoi, Vietnam which was founded in 2006. In 2014, Horby established the Epidemic Research Group Oxford . ERGO incorporates a number of international projects such as the European Commission funded PREPARE, the African coaLition for Epidemic Research, Response and Training , and the International Severe Acute Respiratory and emerging Infection Consortium . Since 2016, Horby has been chair and executive director of ISARIC.
Peter Horby's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A novel coronavirus outbreak of global health concern (2020) (5799)
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 (2020) (4463)
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report (2020) (4350)
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial (2020) (2820)
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study (2020) (2363)
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. (2020) (1694)
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. (2012) (1156)
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (1083)
- Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19 (2020) (1040)
- A minimal common outcome measure set for COVID-19 clinical research (2020) (939)
- Genetic mechanisms of critical illness in COVID-19 (2020) (887)
- Avian influenza A (H5N1) in 10 patients in Vietnam. (2004) (843)
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score (2020) (590)
- A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 (2012) (540)
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2020) (516)
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. (2016) (467)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study (2020) (451)
- Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures (2006) (429)
- Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study (2020) (399)
- Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol (2020) (397)
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. (2021) (391)
- Global health security: the wider lessons from the west African Ebola virus disease epidemic (2015) (388)
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial (2021) (351)
- Mapping the zoonotic niche of Ebola virus disease in Africa (2014) (349)
- A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. (2002) (321)
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (316)
- Antibody landscapes after influenza virus infection or vaccination (2014) (316)
- Nonpharmaceutical Interventions for Pandemic Influenza, International Measures (2006) (314)
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial (2021) (282)
- Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. (2017) (232)
- Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (201)
- The Epidemiology of Hand, Foot and Mouth Disease in Asia (2016) (176)
- Epidemiology, Clinical Manifestations, and Outcomes of Streptococcus suis Infection in Humans (2014) (173)
- A national outbreak of multi-resistant Salmonella enterica serovar Typhimurium definitive phage type (DT) 104 associated with consumption of lettuce (2003) (172)
- Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study (2014) (171)
- Australia's health 2002 : the eighth biennial report of the Australian Institute of Health and Welfare (2002) (164)
- Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (162)
- A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. (2010) (158)
- Global epidemiology of avian influenza A(H5N1) virus infection in humans, 1997 – 2015: a systematic review (2016) (153)
- Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam (2013) (151)
- Randomised controlled trials for Ebola: practical and ethical issues (2014) (147)
- Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. (2009) (142)
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial (2016) (141)
- Social Contact Patterns in Vietnam and Implications for the Control of Infectious Diseases (2011) (140)
- Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. (2018) (140)
- A novel coronavirus outbreak of global health concern - Comment - Correction (2020) (140)
- Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study (2021) (136)
- The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review (2014) (135)
- The Breadth of Viruses in Human Semen (2017) (124)
- Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review (2020) (123)
- Streptococcus suis, an Important Cause of Adult Bacterial Meningitis in Northern Vietnam (2009) (121)
- Whole-genome sequencing reveals host factors underlying critical COVID-19 (2022) (120)
- Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (116)
- Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection. (2019) (114)
- Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1 (2014) (111)
- The Role of Host Genetics in Susceptibility to Influenza: A Systematic Review (2012) (106)
- Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases (2016) (103)
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021) (98)
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021) (98)
- COVID-19 and risks to the supply and quality of tests, drugs, and vaccines (2020) (98)
- How the COVID-19 pandemic will change the future of critical care (2021) (95)
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK (2021) (94)
- Lack of SARS Transmission among Public Hospital Workers, Vietnam (2004) (93)
- Immunological and Viral Determinants of Dengue Severity in Hospitalized Adults in Ha Noi, Viet Nam (2011) (92)
- Severe Pandemic H1N1 2009 Infection Is Associated with Transient NK and T Deficiency and Aberrant CD8 Responses (2012) (85)
- Avian influenza H5N1 in viverrids: implications for wildlife health and conservation (2006) (85)
- Ethnicity and Outcomes from COVID-19: The ISARIC CCP-UK Prospective Observational Cohort Study of Hospitalised Patients (2020) (84)
- Experimental Treatment of Ebola Virus Disease with Brincidofovir (2016) (82)
- Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern Vietnam (2008) (81)
- Influenza Infection Rates, Measurement Errors and the Interpretation of Paired Serology (2012) (80)
- Open source clinical science for emerging infections (2013) (80)
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis (2022) (80)
- Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19 (2021) (79)
- Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza (2008) (77)
- Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study (2021) (77)
- Edinburgh Research Explorer Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study (2020) (72)
- Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis (2017) (70)
- Vaccine-preventable diseases and vaccination coverage in Australia, 1999-2000. (2002) (70)
- Quantifying the Emergence of Dengue in Hanoi, Vietnam: 1998–2009 (2011) (69)
- Social and environmental determinants of malaria in space and time in Viet Nam. (2011) (68)
- The Epidemiology of Interpandemic and Pandemic Influenza in Vietnam, 2007–2010 (2012) (65)
- Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection. (2015) (64)
- Seasonality of absolute humidity explains seasonality of influenza-like illness in Vietnam. (2015) (63)
- Understanding and Managing Zoonotic Risk in the New Livestock Industries (2013) (62)
- What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? (2010) (61)
- Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 (2020) (60)
- Insights from clinical research completed during the west Africa Ebola virus disease epidemic. (2017) (60)
- Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. (2020) (59)
- Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003 (2006) (58)
- Contribution The Epidemiology of Interpandemic and Pandemic Influenza in Vietnam , 2007 – 2010 The Ha Nam Household Cohort Study I (2012) (56)
- Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial (2020) (56)
- Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. (2003) (56)
- Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK (2021) (56)
- Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease (2015) (55)
- Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study (2021) (55)
- Prospects for Emerging Infections in East and Southeast Asia 10 Years after Severe Acute Respiratory Syndrome (2013) (55)
- Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam (2012) (54)
- H7N9 is a virus worth worrying about (2013) (53)
- The global war on terrorism. (2007) (52)
- IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza (2017) (51)
- International Severe Acute Respiratory and emerging Infections Consortium Partners^ (2016) (51)
- CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement (2016) (50)
- Avian influenza A(H7N9) and the closure of live bird markets. (2013) (49)
- Klebsiella pneumoniae Oropharyngeal Carriage in Rural and Urban Vietnam and the Effect of Alcohol Consumption (2014) (49)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- Using computer simulations to compare pertussis vaccination strategies in Australia. (2004) (48)
- Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000 This report was written at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) by: (2002) (48)
- Global epidemiology of avian infl uenza A H5N1 virus infection in humans, 1997–2015: a systematic review of individual case data (2016) (48)
- Furious Rabies after an Atypical Exposure (2009) (47)
- An updated systematic review of the role of host genetics in susceptibility to influenza (2013) (46)
- Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission (2019) (45)
- Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel (2019) (45)
- Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort☆ (2014) (45)
- Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses (2009) (43)
- Human plague: An old scourge that needs new answers (2020) (42)
- Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study (2021) (42)
- Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis (2020) (40)
- The Spectrum of Central Nervous System Infections in an Adult Referral Hospital in Hanoi, Vietnam (2012) (40)
- Fatal Respiratory Infections Associated with Rhinovirus Outbreak, Vietnam (2012) (39)
- A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods (2004) (39)
- Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. (2012) (39)
- Determinants of Influenza Transmission in South East Asia: Insights from a Household Cohort Study in Vietnam (2014) (38)
- Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases. (2021) (37)
- Modernising epidemic science: enabling patient-centred research during epidemics (2016) (37)
- Acute febrile myalgia in Vietnam due to trichinellosis following the consumption of raw pork. (2009) (37)
- Core Outcomes Set for Trials in People With Coronavirus Disease 2019 (2020) (37)
- Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection (2015) (35)
- SARS transmission in Vietnam outside of the health-care setting (2006) (34)
- Research priorities for Long Covid: refined through an international multi-stakeholder forum (2021) (34)
- Raw Pig Blood Consumption and Potential Risk for Streptococcus suis Infection, Vietnam (2014) (34)
- Atlas of human infectious diseases. (2012) (34)
- Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 (2021) (32)
- Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus. (2014) (32)
- PHLS overview of communicable diseases 1999. (2001) (30)
- H5N1-SeroDetect EIA and Rapid Test: a Novel Differential Diagnostic Assay for Serodiagnosis of H5N1 Infections and Surveillance (2011) (29)
- Staphylococcus aureus nasopharyngeal carriage in rural and urban northern Vietnam (2014) (29)
- Epidemiology and etiology of influenza-like-illness in households in Vietnam; it’s not all about the kids! (2016) (29)
- Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. (2014) (29)
- Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza (2020) (28)
- Global outbreak research: harmony not hegemony (2020) (28)
- Comparative Outcomes of Adults Hospitalized With Seasonal Influenza A or B Virus Infection: Application of the 7-Category Ordinal Scale (2019) (28)
- Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples (2018) (28)
- Atlas of Human Infectious Diseases: Wertheim/Atlas of Human Infectious Diseases (2012) (28)
- Global outbreak research: harmony not hegemony (2020) (28)
- An evidence-based framework for priority clinical research questions for COVID-19 (2020) (28)
- Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials (2020) (27)
- Subclinical Avian Influenza A(H5N1) Virus Infection in Human, Vietnam (2013) (27)
- Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review (2020) (26)
- Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years (2022) (26)
- A household survey on screening practices of household contacts of smear positive tuberculosis patients in Vietnam (2014) (26)
- A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups (2019) (25)
- Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006–2016 (2019) (25)
- Preparing clinicians for (re-)emerging arbovirus infectious diseases in Europe. (2018) (25)
- Making trials part of good clinical care: lessons from the RECOVERY trial (2021) (25)
- A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus) (2020) (25)
- Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery (2021) (23)
- Assessment of Human-to-Human Transmissibility of Avian Influenza A(H7N9) Virus Across 5 Waves by Analyzing Clusters of Case Patients in Mainland China, 2013–2017 (2018) (23)
- Temporal and spatial association of Streptococcus suis infection in humans and porcine reproductive and respiratory syndrome outbreaks in pigs in northern Vietnam (2015) (22)
- The capability of accident and emergency departments to safely decontaminate victims of chemical incidents (2000) (22)
- Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study (2021) (22)
- Emerging and re-emerging infectious disease threats in South Asia: status, vulnerability, preparedness, and outlook (2017) (21)
- Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review (2022) (21)
- Time to reconsider the role of ribavirin in Lassa fever (2021) (20)
- DodaLab: An urban health and demographic surveillance site, the first three years in Hanoi, Vietnam (2012) (20)
- Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development (2020) (20)
- Person-to-person transmission of influenza A (H5N1) (2008) (19)
- Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection (2018) (18)
- The potential for a controlled human infection platform in Singapore. (2014) (18)
- Ebola virus antibody decay–stimulation in a high proportion of survivors (2021) (18)
- Ebola virus antibody decay–stimulation in a high proportion of survivors (2021) (18)
- The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations (2021) (18)
- Migration and Persistence of Human Influenza A Viruses, Vietnam, 2001–2008 (2013) (18)
- A family cluster of three confirmed cases infected with avian influenza A (H7N9) virus in Zhejiang Province of China (2014) (18)
- Long-term clinical prognosis of human infections with avian influenza A(H7N9) viruses in China after hospitalization (2020) (18)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- Trial design for evaluating novel treatments during an outbreak of an infectious disease (2016) (17)
- Clinical assessment is a neglected component of outbreak preparedness: evidence from refugee camps in Greece (2018) (17)
- A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections (2019) (17)
- Lopinavir-ritonavir in Hospitalised Patients with COVID-19 – a randomised, controlled, open-label, platform trial (2020) (16)
- Acute Measles Encephalitis in Partially Vaccinated Adults (2013) (16)
- Lassa fever in pregnancy: a systematic review and meta-analysis (2020) (16)
- Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009 (2020) (15)
- Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study (2021) (15)
- A dengue outbreak on a floating village at Cat Ba Island in Vietnam (2015) (14)
- Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices (2021) (14)
- Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol (2021) (14)
- Improving preparedness for the next flu pandemic (2018) (14)
- Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England (2021) (14)
- Burden of disease and economic impact of human Streptococcus suis infection in Viet Nam (2019) (14)
- WHO R&D Blueprint novel Coronavirus COVID-19 Animal Models (2020) (13)
- Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic (2017) (13)
- Drivers of Emerging Zoonotic Infectious Diseases (2014) (13)
- Diagnostic Accuracy of Microscopic Observation Drug Susceptibility (MODS) Assay for Pediatric Tuberculosis in Hanoi, Vietnam (2013) (13)
- Performance of different clinical trial designs to evaluate treatments during an epidemic (2018) (13)
- A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot (2019) (13)
- Variant Creutzfeldt‐Jakob disease: An unfolding epidemic of misfolded proteins (2002) (13)
- ISARIC Clinical Data Report issued: 14 July 2021 (2020) (12)
- Ebola: Europe-Africa research collaborations. (2015) (12)
- Can we make human plague history? A call to action (2019) (12)
- Studying the effectiveness of activated carbon R95 respirators in reducing the inhalation of combustion by-products in Hanoi, Vietnam: a demonstration study (2012) (11)
- Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2020) (11)
- Sero-Prevalence Surveillance to Predict Vaccine-Preventable Disease Outbreaks; A Lesson from the 2014 Measles Epidemic in Northern Vietnam (2019) (11)
- Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19 (2021) (11)
- Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans (2020) (11)
- International Biological Reference Preparations for Epidemic Infectious Diseases (2019) (11)
- Strongyloides stercoralis seroprevalence in Vietnam (2017) (10)
- A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic (2019) (10)
- First report of human psittacosis in Vietnam. (2013) (10)
- Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study (2022) (10)
- Community studies of influenza: new knowledge, new questions. (2014) (10)
- Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic (2016) (10)
- Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population (2020) (10)
- Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study (2021) (10)
- Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. (2002) (9)
- Investigation of Dengue and Japanese Encephalitis Virus Transmission in Hanam, Viet Nam (2014) (9)
- Drug assessment in the Ebola virus disease epidemic in west Africa. (2015) (9)
- Measuring Mosquito-borne Viral Suitability in Myanmar and Implications for Local Zika Virus Transmission (2018) (9)
- Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19 (2020) (9)
- Isolation of viable Zika virus from spermatozoa. (2018) (9)
- International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019 (2020) (8)
- Avian influenza – A review for doctors in travel medicine (2009) (8)
- Clinical Trials of Therapeutics for the Prevention of Congenital Zika Virus Disease: Challenges and Potential Solutions (2017) (8)
- Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 (2020) (8)
- Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort (2021) (7)
- Priorities, Barriers, and Facilitators towards International Guidelines for the Delivery of Supportive Clinical Care during an Ebola Outbreak: A Cross-Sectional Survey (2019) (7)
- ISARIC COVID-19 Clinical Data Report: 8 June 2020 (2020) (7)
- Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort (2020) (7)
- Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study (2022) (7)
- Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections (2017) (7)
- Deaths Associated with Pneumonic Plague, 1946–2017 (2020) (6)
- Long-term outcomes of patients with Streptococcus suis infection in Viet Nam: A case-control study (2017) (6)
- Preparedness for clinical research during pandemics: a perspective from the Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) (2018) (6)
- Monkeypox treatment with tecovirimat in the Central African Republic under an Expanded Access Programme (2022) (6)
- Human infection with a reassortment avian influenza A H3N8 virus: an epidemiological investigation study (2022) (6)
- Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing (2022) (6)
- Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis (2020) (6)
- Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017 (2021) (6)
- Early clinical characteristics of Covid-19: scoping review (2020) (6)
- Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study (2020) (6)
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial (2020) (6)
- GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic (2017) (6)
- The burden and dynamics of hospital-acquired SARS-CoV-2 in England (2021) (6)
- Variant Creutzfeldt-Jakob disease in a Canadian resident (2002) (5)
- Emerging Infections in Asia (2009) (5)
- From SARS and MERS to COVID-19: a review of the quality and responsiveness of clinical management guidelines in outbreak settings (2021) (5)
- An evaluation of global Chikungunya clinical management guidelines: A systematic review (2022) (5)
- Defining ELISpot cut-offs from unreplicated test and control wells (2013) (5)
- Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study (2020) (5)
- Temporal relationship between occurrences of hand, foot and mouth disease, respiratory virus detection and febrile seizures in children in tropical Singapore: a time-series analysis (2018) (5)
- Stimulating the development of national Streptococcus suis guidelines in Viet Nam through a strategic research partnership. (2010) (5)
- Dengue in Adults Admitted to a Referral Hospital in Hanoi, Vietnam (2015) (4)
- Hydroxychloroquine for COVID-19: Balancing contrasting claims (2020) (4)
- Why preprints are good for patients (2022) (4)
- Tecovirimat for Monkeypox in the Central African Republic under Expanded Access (2022) (4)
- Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE). (2020) (4)
- Evaluation of the Efficacy and Safety of Intravenous Remdesivir in Adult Patients with Severe Pneumonia caused by COVID-19 virus Infection: study protocol for a Phase 3 Randomized, Double-blind, Placebo-controlled, Multicentre trial (2020) (4)
- Short period incidence sTudy of severe acute respiratory infection (SPRINT-SARI) initial data from a global observational study to better describe SARI epidemiology in critically ill patients (2016) (4)
- Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial (2022) (4)
- Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply (2021) (4)
- Influenza A H5N1 and HIV co-infection: case report (2010) (4)
- SARS: UK public health response--past, present and future. (2003) (4)
- Population susceptibility to a variant swine-origin influenza virus A(H3N2) in Vietnam, 2011–2012 (2015) (3)
- One year experience using mycobacterial blood cultures to diagnose tuberculosis in patients with prolonged fever in Vietnam (2014) (3)
- Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply. (2021) (3)
- Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies (2022) (3)
- Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries (2019) (3)
- Strengthening preparedness for (re-) emerging arboviruses in Europe. (2018) (3)
- Correction: Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern Vietnam (2008) (3)
- Core Minimal Datasets to Advance Clinical Research for Priority Epidemic Diseases (2019) (3)
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol (2020) (3)
- Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review (2021) (3)
- Remote-Controlled and Pulse Pressure–Guided Fluid Treatment for Adult Patients with Viral Hemorrhagic Fevers (2021) (3)
- Social Contact Data for Vietnam (2018) (2)
- COVID-19 can be called a treatable disease only after we have antivirals (2022) (2)
- Online video sharing and patients’ privacy (2009) (2)
- Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients (2020) (2)
- A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever (2022) (2)
- Recent evolution patterns of Ebola virus inferred from patient samples collected from February-May 2015 with direct deep sequencing in Sierra Leone. (2015) (2)
- 20.130 ISARIC – enhancing the clinical research response to epidemics (2016) (2)
- Core outcome measures for trials in people with COVID-19: respiratory failure, multiorgan failure, shortness of breath and recovery (2020) (2)
- Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. (2023) (2)
- An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients (2022) (2)
- The within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children (2021) (2)
- Serological Evidence of Human Infection With Avian Influenza A(H7N9) Virus: A Systematic Review and Meta-analysis (2020) (2)
- A prototype lateral flow assay for detection of orthopoxviruses. (2022) (2)
- The effect of hand hygiene frequency on reducing acute respiratory infections in the community: a meta-analysis (2022) (2)
- From severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) to coronavirus disease 2019 (COVID-19): a systematic review of the quality and responsiveness of clinical management guidelines in outbreak settings (2021) (2)
- Facilitating participation in clinical trials during pregnancy (2023) (2)
- Correction: Diagnostic Accuracy of Microscopic Observation Drug Susceptibility (MODS) Assay for Pediatric Tuberculosis in Hanoi, Vietnam (2013) (2)
- Innovations in public health surveillance: updates from a forum convened by the WHO Hub for Pandemic and Epidemic Intelligence, 2 and 3 February 2022 (2022) (1)
- First case of variant Creutzfeldt-Jakob disease reported in Italy - update (2002) (1)
- Why are so few people infected with influenza A (H5N1) despite a large exposed population? The role of host genetics (2010) (1)
- Correction: GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic (2018) (1)
- A training curriculum for conducting clinical research during outbreaks (2017) (1)
- of Birmingham Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol (2020) (1)
- Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel (2019) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- Single-nucleotide polymorphisms of IFITM3, TLR3, CD55, and TLR4 and risk for severe outcomes in patients with influenza A (H7N9) and (H1N1)pdm09 in China: a multicentre cohort study (2017) (1)
- For some groups traditionally considered to be ‘high risk’, the evidence of an increased risk of severe influenza-associated illness is poor quality (2013) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023) (1)
- Seasonality and its impact on COVID-19 (2020) (1)
- Avian, inter-pandemic, and pandemic influenza in Vietnam (2012) (1)
- New data on clinical features, incubation period, and case fatality rate of SARS in Hong Kong and Canada (2003) (1)
- Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations (2021) (1)
- Measuring mosquito-borne viral suitability and its implications for Zika virus transmission in Myanmar (2018) (1)
- Haemophilia A in the highlands: the investigation and management of two families in Tari. (1993) (1)
- Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2022) (1)
- Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children (2021) (1)
- Perspectives of patients, family members, health professionals and the public on the impact of COVID-19 on mental health (2022) (1)
- Evaluation of S/F94 as a proxy for COVID-19 severity (2022) (1)
- Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study (2014) (1)
- Rendering beef safe. (2002) (1)
- Harmonisation of research data for congenital Zika syndrome: need for core data sets for epidemic-prone infectious diseases (2019) (1)
- Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases (2022) (0)
- Absolute humidity drives the epidemiology of influenza-like illness in Vietnam (2017) (0)
- Systematic review and meta-analysis on the epidemiology, clinical manifestations, and outcome of Streptococcus suis infection (2014) (0)
- Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs. (2023) (0)
- INTERNATIONAL BIOLOGICAL REFERENCE PREPARATIONS FOR EMERGING INFECTIOUS DISEASES: VITAL TOOLS IN EPIDEMIC PREPAREDNESS (2018) (0)
- Vector control to eliminate artemisinin resistant malaria in the Greater Mekong subregion (2014) (0)
- Benefits from using leftover tissue without consent (2017) (0)
- Author response: Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children (2021) (0)
- Quantifying the emergence of dengue inCE OF DENGUE IN HANOI, 1998-2009 (2011) (0)
- Severe Acute Respiratory Syndrome: international update (2003) (0)
- First global consultation on SARS, 16-17 May (2003) (0)
- Case reportInfluenza A H 5 N 1 and HIV co-infection : case report (2016) (0)
- Upsurge in Salmonella typhimurium DT104 in England and Wales (2000) (0)
- PFGE after SmaI digestion of Streptococcus suis serotype 2 strains isolated from patients in northern Vietnam. (2013) (0)
- Seroepidemiology of enterovirus A71 infection in prospective cohort studies of children in southern China, 2013-2018 (2022) (0)
- Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines (2022) (0)
- Whole genome sequencing identifies multiple loci for critical 1 illness caused by COVID-19 2 (2021) (0)
- Clinical research networks and assessing pandemic severity (2018) (0)
- Peter Horby*, Le Quynh Mai, Annette Fox, Pham Quang Thai, Nguyen Thi Thu Yen, Le Thi Thanh, (2012) (0)
- Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2023) (0)
- Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices (2021) (0)
- Randomised controlled trials for mpox in endemic countries (2023) (0)
- Ebola: Europe-Africa research collaborations (vol 15, pg 1258, 2015) (2015) (0)
- Fatal Lower Respiratory Tract Infections with Rhinovirus A in Infants in Vietnam (2008) (0)
- Emerging infectious diseases in Asia (2014) (0)
- SHORT REPORT Strongyloides stercoralis seroprevalence in Vietnam (2017) (0)
- Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2022) (0)
- Whole genome sequencing reveals host factors underlying critical Covid-19 Accelerated Article Preview (2022) (0)
- Allocated but not treated: the silent 16% – Authors' reply (2022) (0)
- Treatment and outcomes of acute coronary syndromes in India (CREATE) : a prospective analysis of registry data. Commentaries (2008) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- In response [11] (2007) (0)
- RapiD_AI: A framework for Rapidly Deployable AI for novel disease & pandemic preparedness (2022) (0)
- Determining risk factors for infection with influenza A (H5N1) - Response (2007) (0)
- Multisystem diseases and infections (2021) (0)
- Analysis of H5N1 specific T cell responses in a high risk cohort in VietNam indicates possible asymptomatic infection (2010) (0)
- Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study (2023) (0)
- The making of a world atlas of infectious diseases (2010) (0)
- CLINICAL CHARACTERISTICS OF PATIENTS ADMITTED TO PNEUMONIC PLAGUE TREATMENT CENTERS DURING THE 2017 MADAGASCAR PNEUMONIC PLAGUE OUTBREAK: A PROSPECTIVE OBSERVATIONAL STUDY (2018) (0)
- Cluster of wound botulism cases in injecting drug users in England - update (2002) (0)
- The prevalence of variant Creutzfeldt-Jakob disease: new data and plans for a tonsil archive (2002) (0)
- Science in a crisis: conducting clinical trials in an emergency (2015) (0)
- Design of Vaccine Efficacy Trials for Priority Emerging and Epidemic Diseases (2019) (0)
- TAYLOR AND OTHERS (2015) (0)
- Case report Influenza A H5N1 and HIV co-infection: case report (2010) (0)
- Author Correction: Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 (2021) (0)
- Teaching research methodology within an Ebola virus outbreak (2016) (0)
- Factors In fl uencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study (2020) (0)
- UK further restricts the practice of selected hepatitis C infected healthcare workers (2002) (0)
- Improving preparedness for the next flu pandemic (2018) (0)
- Association Of Respiratory Viruses and Hand, Foot, and Mouth Disease With Hospital Attendance for Febrile Seizures and Epilepsy in Singapore (2015) (0)
- Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean subjects (2020) (0)
- Ebola virus disease in pregnancy: a systematic review and meta-analysis (2021) (0)
- Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme (2022) (0)
- The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection (2023) (0)
- Cluster of wound botulism cases in injecting drug users in England (*see footnote) (2002) (0)
- 132 – Viral Hemorrhagic Fevers (2017) (0)
This paper list is powered by the following services:
Other Resources About Peter Horby
What Schools Are Affiliated With Peter Horby?
Peter Horby is affiliated with the following schools:
